Vepdegestrant could extend PFS for some ESR1-mutated advanced breast cancers

Olaparib boosts chemotherapy’s impact on BRCA-mutated breast cancer

Managing gastrotoxicities for RCC treatment – Gastroenterologist's perspective

WRN inhibitor shows promise in patients with MSI and/or dMMR advanced solid tumours

Olaparib plus pembrolizumab shows promising results in BRCA mutated cancers

A conversational artificial intelligence system enhances precision medicine and health equity

Exploring colorectal cancer in Hispanic/Latino populations through multi-omics analysis of MYC gene and WNT signalling pathway alteration

Metastasis-directed radiotherapy shows good prognosis for oligometastatic kidney cancer

Circulating tumour DNA can guide adjuvant immunotherapy for mismatch repair-deficient tumours

Penpulimab in combination with chemotherapy for metastatic nasopharyngeal cancer shows positive results

Addition of pembrolizumab to standard care shows promising results in advanced head and neck cancer

EGFR shows to be a promising therapeutic target in NF1 mutant melanoma